Overview

In the first funding period (2019 to 2022) of the Collaborative Research Centre 1350, researchers from basic science fields and clinical disciplines at Universit?t Regensburg and Friedrich-Alexander-Universit?t Erlangen-Nürnberg joined forces to study the tubulointerstitium. In the present funding period (2023 to 2026), the successful research of CRC 1350 is continued as Transregio TRR 374 - funded by the German Research Foundation (DFG).

??????

Spokesperson
Prof. Dr. Richard?Warth
Medical?Cell Biology
Universit?tsstr. 31
D-93053 Regensburg
Tel.: ++49 941/943 2894
Email: richard.warth@ur.de

Vice Spokespersons
Prof. Dr.?Frank?Schweda
Institute of Physiology
Universit?tsstr. 31
D-93053 Regensburg
Tel.: ++49 941/943 2957
Email: frank.schweda@ukr.de

Prof. Dr. Kerstin Amann
Nephropathology
Krankenhausstr. 8-10
D-91054 Erlangen
Tel.: ++49 9131/85 22291
Email: kerstin.amann@uk-erlangen.de

Prof. Dr. Mario Schiffer
Medizinische Klinik 4 - Nephrologie und Hypertensiologie
Ulmenweg 18
D-91054 Erlangen
Tel.: ++49 9131/85 39002
Email: mario.schiffer@uk-erlangen.de

? ??

Executive Board:
Kerstin Amann, Erlangen (vice spokesperson)
Silke H?rteis, Regensburg
Janina Müller-Deile, Erlangen
Michaela Kritzenberger, Regensburg (gender equality officer)
Matthias Mack,?Regensburg
Mario Schiffer, Erlangen (vice spokesperson)
Frank Schweda,?Regensburg (vice spokesperson)
Bettina Firmke (representative of the doctoral students)
Richard?Warth,?Regenburg (spokesperson)
Michael Wiesener, Erlangen